Paul Thomas Shoun - Jul 31, 2025 Form 4 Insider Report for Expion360 Inc. (XPON)

Role: President, Director
Signature: /s/ Brian Schaffner, Attorney-in-Fact for Paul Thomas Shoun
Stock symbol: XPON
Transactions as of: Jul 31, 2025
Transactions value $: $0
Form type: 4
Date filed: 8/1/2025, 09:58 PM
Previous filing: Apr 10, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Shoun Paul Thomas	President, Director	2025 SW DEERHOUND AVE, REDMOND	/s/ Brian Schaffner, Attorney-in-Fact for Paul Thomas Shoun	2025-08-01	0001921734

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XPON	Stock Option (Right to Buy)	Award	$0	+46.3K		$0.00	46.3K	Jul 31, 2025	Common Stock	46.3K	$0.77	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The exercise price of the Options (as defined below) was determined based on the closing price of the Issuer's common stock, par value $0.001 per share, on the date the Options were conditionally approved by the compensation committee of the board of directors.
F2	Reflects a grant of stock options (the "Options") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "Plan"). The Options were approved by the compensation committee of the board of directors on April 9, 2025, subject to stockholder approval of an increase in the number of shares available for issuance under the Plan under which the Options were granted (the "Plan Amendment"). The Plan Amendment was approved by stockholders on July 31, 2025. The Options vested in full and became immediately exercisable on July 31, 2025.

Content

The exercise price of the Options (as defined below) was determined based on the closing price of the Issuer's common stock, par value $0.001 per share, on the date the Options were conditionally approved by the compensation committee of the board of directors.

Reflects a grant of stock options (the "Options") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "Plan"). The Options were approved by the compensation committee of the board of directors on April 9, 2025, subject to stockholder approval of an increase in the number of shares available for issuance under the Plan under which the Options were granted (the "Plan Amendment"). The Plan Amendment was approved by stockholders on July 31, 2025. The Options vested in full and became immediately exercisable on July 31, 2025.